CIK 0001855175 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Contineum Therapeutics, Inc.
Sign in to watch- Ticker
- CTNM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 271467257
- Phone
- (858) 333-5280
- Business address
- 3565 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO, CA, 92121
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure
- 4 Planned sale Chief Scientific Officer sold 1,040 shares at $16.00 ($16,640)
- 4 Planned sale CEO and President sold 2,500 shares at $16.00 ($40,000)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Scientific Officer sold 37,179 shares at an average $15.99 ($594,578)
- 4 Planned sale CMO & Head of Development sold 10,833 shares at $16.02 ($173,590)
- 4 Planned sale CEO and President sold 10,000 shares at $16.01 ($160,080)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
Page 2 of 11 · 202 filings